NYSE · Drug Manufacturers - General

JNJ (JNJ) Stock

$270.47 +1.74% NYSE: JNJ Healthcare

Valuation

MetricValue
Price$270.47
Market Cap$651.81B
P/E Ratio31.21
P/B Ratio7.75
P/S Ratio6.64
EPS (TTM)$11.03
52-Week High$276.47
52-Week Low$173.33
Dividend Yield1.99%

Financials & Margins

MetricValue
ROE25.74%
ROA10.46%
ROCE17.96%
Gross Margin69.12%
Operating Margin26.87%
Net Margin21.48%
Debt/Equity0.58
Current Ratio1.03

Annual Financials (USD)

Metric20212022202320242025
Revenue$78.7B$80.0B$85.2B$88.8B$94.2B
Operating Profit$20.9B$21.0B$23.4B$22.1B$25.6B
Net Profit$20.9B$17.9B$35.2B$14.1B$26.8B
EPS$7.81$6.73$13.72$5.79$11.03
Op Margin26.6%26.3%27.5%24.9%27.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$182.0B$187.4B$167.6B$180.1B$199.2B
Total Liabilities$108.0B$110.6B$98.8B$108.6B$117.7B
Cash$14.5B$12.9B$21.9B$24.1B$19.7B
Borrowings$33.8B$39.6B$29.3B$36.6B$47.9B

Latest News

The Dividend Growth Plan That Leaves High-Yield Stocks Behind 24/7 Wall St. · Jul 11, 2026 Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine 24/7 Wall St. · Jul 11, 2026 The Retirement Budget Most People Build Is Backward 24/7 Wall St. · Jul 11, 2026 Volatility Isn’t the Risk You Should Fear — These Are 24/7 Wall St. · Jul 11, 2026 Should You Buy Eli Lilly Stock? Here's My Honest Take. Motley Fool · Jul 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$23.4B$21.2B$22.8B$24.3B$24.5B
Investing Cash Flow$-12.3B$-16.4B$-3.7B$-23.0B$-28.4B
Financing Cash Flow$-2.0B$-4.6B$-5.6B$-1.4B$-2.8B
Net Cash Flow$502.0M$-360.0M$7.7B$2.2B$-4.4B
Free Cash Flow$19.8B$17.2B$18.2B$19.8B$19.7B

Valuation & Return Ratios

MetricValue
PEG Ratio-3.86
EV / EBITDA20.14
FCF Yield2.88%
Quick Ratio0.81
Interest Coverage25.94
Return 1Y56.22%
Return 3Y77.65%
Return 5Y78.95%

Ownership

Insiders Held0.05%
Institutions Held76.85%
Institutions Float Held76.89%
Institutional HolderSharesReport Date
Blackrock Inc.213,385,5462026-03-31
Vanguard Capital Management LLC156,605,3702026-03-31
State Street Corporation133,476,2882026-03-31
Vanguard Portfolio Management LLC63,514,4362026-03-31
JPMORGAN CHASE & CO63,096,3442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABBV $260.17 +1.46% 74.06 $459.67B 2.63%
AMGN $435.89 +1.40% 27.15 $235.25B 2.29%
AZN $161.96 -0.10% 24.78 $251.18B 1.28%
GILD $148.94 +1.78% -56.96 $184.92B 2.21%
MRK $149.59 +1.24% 121.55 $369.46B 2.22%

About JNJ

JNJ is led by CEO Joaquin Duato, employs 138,100 people, headquartered in New Brunswick, US, publicly traded since 1943.

JNJ stock trades at $270.47 with a market capitalization of $651.81B. The stock is valued at a price-to-earnings (P/E) ratio of 31.21, price-to-book of 7.75, price-to-sales of 6.64. Over the past 52 weeks the stock has ranged between $173.33 and $276.47, and currently trades 2.2% below its 52-week high. It pays a dividend yielding 1.99%.

On profitability, JNJ generates a return on equity (ROE) of 25.74% — well above the market average, a sign of a high-quality business, return on capital employed of 17.96%, an operating margin of 26.87%, a net profit margin of 21.48%.

In its most recent fiscal year, JNJ reported annual revenue of $94.2B, net profit of $26.8B, revenue has compounded at 2.7% a year over the last five years, profit at 12.7% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.58, a current ratio of 1.03, total assets of $199.2B, $19.7B in cash and equivalents.

JNJ has an average daily trading volume of 7,778,068 shares, a beta of 0.23 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides